Xeris Biopharma Holdings, Inc. (XERS) stock analysis

XERS · Xeris Biopharma Holdings, Inc.

Latest recorded price: USD 16.70

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

A reliable intrinsic value could not be calculated for XERS; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 38.3%, ROIC 27.2%.

Similar companies in Healthcare